Activation of the interleukin‐10 gene in the human T lymphoma line HuT 78: identification and characterization of NF‐κ B binding sites in the regulatory region of the interleukin‐10 gene
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Interleukin‐10 (IL‐10) is a pleiotropic cytokine which has potent inhibitory effects on macrophages and T cells, and contributes to the regulation of proliferation and differentiation of B cells. Resting HuT 78, a T‐cell line derived from a Sezary lymphoma, produced significant amounts of IL‐10 compared with another T‐cell line, Jurkat. To elucidate the mechanisms by which the IL‐10 is expressed, we have analyzed their activity in human T‐cell lines. We report here evidence that members of the family of transcription factors nuclear factor‐κ B (NF‐κ B)/Rel can specifically recognize 3 identical sequences located in the 5′‐regulatory region of IL‐10 gene in resting HuT 78 cells, whereas Jurkat cells expressed high levels of NF‐κ B consisting of p65 and p50 only upon activation with tumor necrosis factor‐α (TNF‐α). In HuT 78 cells, p50 was the major component in the NF‐κ B complexes. Exogenous TNF‐α and the monoclonal antibody to TNF‐α did not affect IL‐10 production and constitutive NF‐κ B binding levels in HuT 78 cells. This study is the first demonstration of a role for NF‐κ B in the IL‐10 gene expression, and suggests that its expression does not require TNF‐α. These novel findings may account for the specific IL‐10 gene expression in T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., & Banchereau, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1890 · Cited by 1,238
Cited by
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
The regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
Fleetwood, A. J., Lawrence, T., Hamilton, J. A., & Cook, A. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5245 · Cited by 607
“Consistent with this observation, IL-10 expression was found to relate to high levels of p50 expression (46), and the inhibition of RelA-containing complexes up-regulated IL-10 production (47).”
BackgroundInterleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding
Schottelius, A. J. G., Mayo, M. W., Sartor, R. B., & Baldwin, A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31868 · Cited by 532
Vulevic, J., Drakoularakou, A., Yaqoob, P., Tzortzis, G., & Gibson, G. R. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26242 · Cited by 451
Metadata
- Authors
- Mori, N., & Prager, D.
- Venue
- European Journal of Haematology
- Publisher
- Wiley
- Published
- 1997-09
- Volume
- 59
- Issue
- 3
- Pages
- 162-170
- ISSN
- 0902-4441 (ISSN-L)
- 1600-0609
- OpenAlex
- W2028016215
- Cited by
- 47
- References
- 1
- FWCI
- 0.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activation of the interleukin‐10 gene in the human T lymphoma line HuT 78: identification and characterization of NF‐κ B binding sites in the regulatory region of the interleukin‐10 gene. https://app.cochat.ai/papers/10.1111/j.1600-0609.1997.tb00970.x
- The paper
- Mori, N., & Prager, D. (1997). Activation of the interleukin‐10 gene in the human T lymphoma line HuT 78: identification and characterization of NF‐κ B binding sites in the regulatory region of the interleukin‐10 gene. European Journal of Haematology. https://doi.org/10.1111/j.1600-0609.1997.tb00970.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.